Nova Eye Medical Limited
ELXMF
$0.00
-$0.10-98.10%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 37.17% | 39.08% | -12.57% | -10.45% | 4.11% |
| Total Depreciation and Amortization | -13.46% | -16.11% | -31.89% | -33.18% | 0.56% |
| Total Amortization of Deferred Charges | 7.63% | 4.42% | 33.59% | 34.85% | -31.68% |
| Total Other Non-Cash Items | -106.48% | -106.30% | 511.03% | 503.52% | 1,860.36% |
| Change in Net Operating Assets | -- | -- | 73.69% | 74.17% | -- |
| Cash from Operations | 35.35% | 37.32% | 32.18% | 33.45% | 14.21% |
| Capital Expenditure | -48.51% | -43.59% | -1,073.21% | -1,048.21% | 52.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.38% | 7.09% | -492.31% | -476.92% | 61.73% |
| Cash from Investing | -32.05% | -28.10% | -962.32% | -940.58% | 55.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -10.23% | -10.23% | -41.85% | -41.85% | -5.39% |
| Issuance of Common Stock | -- | -- | -16.97% | -16.97% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -10.99% | -7.63% | -20.74% | -22.22% | -5.42% |
| Foreign Exchange rate Adjustments | 152.78% | 144.85% | -14,242.86% | -13,942.86% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 37.08% | 39.00% | -23.17% | -24.61% | 19.02% |